跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 120 条关于
“PBS293-exatecan”
全部
120
临床试验
42
药物
16
机构
0
资讯
62
上个月
Promatix Biosciences Awarded Innovate UK Grant to Advance First-in-Class EGFR × EphA2 Cis-Bispecific ADC
6个月前
Promatix Biosciences Reports 50-Fold Potency Improvement with Novel Bispecific ADC for Colorectal Cancer
2个月前
Innate Pharma Completes Enrollment in Phase 1 Dose Escalation of IPH4502, a Novel Nectin-4 Exatecan ADC, with Preliminary Data Expected by Year-End
3天前
Avacta Reports Clinical Proof of Mechanism for FAP-Activated Exatecan PDC AVA6103 in Phase 1 FOCUS-01
11个月前
Kivu Bioscience Initiates First-in-Human Trial of KIVU-107, Next-Generation PTK7-Targeting ADC for Advanced Solid Tumors
去年
Heidelberg Pharma to Showcase Novel ADC Technologies Targeting Gastrointestinal Cancers at AACR 2025
9个月前
Sutro Biopharma Initiates Phase 1 Trial of STRO-004, Next-Generation Tissue Factor ADC for Advanced Solid Tumors
去年
Avacta's pre|CISION™ Platform Shows Promise in Targeted Cancer Therapy
去年
Tubulis' ADC TUB-030 Enters Phase I/IIa Trial for Advanced Solid Tumors
12个月前
Tubulis Reports Promising Phase I/IIa Data for TUB-040 ADC in Platinum-Resistant Ovarian Cancer
第 1 页,共 7 页
上一页
下一页